drugset / Trial / NCT01265108

Effects of Iron on Exercise Capacity During Hypoxia

NCT01265108

Phase 1 Completed 12 enrolled University of Oxford
Non-randomizedCrossoverDouble-blindBasic science

Summary

During alveolar hypoxia, for example at high altitude or in patients with respiratory disease, there is evidence to suggest that hypoxia-induced pulmonary hypertension might limit exercise performance. Intravenous iron supplementation has recently been shown to reverse pulmonary hypertension in healthy humans at high altitude, and to prevent pulmonary hypertension in volunteers exposed to hypoxia at sea level. The investigators hypothesized that intravenous iron supplementation would enhance exercise capacity during alveolar hypoxia.

Timeline

Start
2010-11
Primary completion
2015-01
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 200 mg Intravenous

Indications

No indication recorded.